An unidentified AI model called Ox Alpha stuns the tech world with frontier-level coding power and no known creator, while Lady Gaga's startup unveils living skin tech that slashes skincare discovery timelines, and Google's Gemini Canvas transforms spreadsheet data into shareable interactive dashboards instantly.
AI agents are transforming industries at record speed, with Anthropic's Claude crushing drug design benchmarks at up to 35% success rates, Uber slashing two-day financial reports to 10 minutes using lean AI pods, and Replit scaling usage 30x by offering free access to powerful AI models.
Former OpenAI executive Fidji Simo launches ChronicleBio, an AI-powered startup using home blood draws and 153 terabytes of biological data to identify chronic disease sub-groups and improve clinical drug trial success rates.
A consortium of AI companies including Loka, AWS, and Arcee AI releases Trinity Mini, an open 26-billion-parameter biomedical reasoning model trained with reinforcement learning that achieves 81.2% drug evaluation accuracy, offering organizations an auditable, deployable solution for specialized scientific AI within controlled infrastructure.
Google DeepMind has quietly disbanded its Nobel Prize-winning AlphaFold team less than a year after its historic 2024 Nobel Prize, with key researchers including Nobel co-winner John Jumper defecting to rival Anthropic, which just launched Claude Science to target the biology and drug-discovery space AlphaFold helped pioneer.
AI is slashing drug development costs by up to 70% and driving a projected $1 billion surge in new biopharma spending, but critics warn that no AI-discovered drug has yet received FDA approval, and the industry's notorious 90% failure rate may persist if human biological variability isn't properly addressed before …
Anthropic launches an internal drug discovery program targeting neglected diseases and unveils Claude Science, a new AI tool for drugmakers, positioning itself as a hands-on healthcare player alongside tech giants like Alphabet, Apple, and Amazon.
Google Cloud launches SandboxAQ's quantitative AI models and a new Gemini for Science suite, giving enterprise and research teams powerful tools to accelerate drug discovery, materials science, and semiconductor R&D by combining scientific numerical AI with Gemini's reasoning capabilities.
Isomorphic Labs, the AI-driven drug discovery spinout from Google DeepMind, is closing in on a massive $2 billion funding round led by Thrive Capital, with Alphabet also joining the deal.
IBM, Cleveland Clinic, and Riken achieve a quantum computing breakthrough by simulating a 12,635-atom protein complex — a massive leap from just 10 atoms in October 2024 — unlocking powerful new possibilities for drug discovery and disease treatment.